Welcome to LookChem.com Sign In|Join Free
  • or
diethyl (2-(3,4-difluorophenyl)-1-(3-methylbenzo[b]thiophen-2-yl)ethyl)phosphonate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

957056-06-3

Post Buying Request

957056-06-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

957056-06-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 957056-06-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,0,5 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 957056-06:
(8*9)+(7*5)+(6*7)+(5*0)+(4*5)+(3*6)+(2*0)+(1*6)=193
193 % 10 = 3
So 957056-06-3 is a valid CAS Registry Number.

957056-06-3Relevant academic research and scientific papers

The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists

Matthews, Jay M.,Qin, Ning,Colburn, Raymond W.,Dax, Scott L.,Hawkins, Mike,McNally, James J.,Reany, Laura,Youngman, Mark A.,Baker, Judith,Hutchinson, Tasha,Liu, Yi,Lubin, Mary Lou,Neeper, Michael,Brandt, Michael R.,Stone, Dennis J.,Flores, Christopher M.

, p. 2922 - 2926 (2012/06/04)

A series of benzothiophene-based phosphonates was synthesized and many analogs within the series were shown to be potent antagonists of the TRPM8 channel. The compounds were obtained as a racemic mixture in 5 synthetic steps, and were tested for TRPM8 antagonist activity in a recombinant, canine TRPM8-expressing cell line using a fluorometric imaging plate reader (FLIPR) assay. Structure-activity relationships were developed initially by modification of the core structure and subsequently by variation of the aromatic substituents and the phosphonate ester. Compound 9l was administered intraperitoneally to rats and demonstrated engagement of the TRPM8 target in both prevention and reversal-modes in an icilin-induced 'wet-dog' shake model.

COLD MENTHOL RECEPTOR-1 ANTAGONISTS

-

Page/Page column 53, (2012/03/12)

The invention is directed to TRPM8 antagonists of Formula (I). More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating TRPM8-mediated disorders. Pharmaceutical and veterinary compositions and methods of treating pain and various other disease states or conditions using compounds of the invention are also described.

COLD MENTHOL RECEPTOR-1 ANTAGONISTS

-

Page/Page column 53, (2012/07/28)

The invention is directed to TRPM8 antagonists of Formula (I). More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating TRPM8-mediated disorders. Pharmaceutical and veterinary compositions and methods of treating pain and various other disease states or conditions using compounds of the invention are also described.

COLD MENTHOL RECEPTOR-1 ANTAGONISTS

-

Page/Page column 168-169; 170, (2008/06/13)

The invention is directed to TRPM8 antagonists of Formula (I). More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating TRPM8-mediated disorders. Pharmaceutical and veterinary compositions and methods of treating pain and various other disease states or conditions using compounds of the invention are also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 957056-06-3